EC229 Economics of Strategy Introduction 1. GlaxoSmithKline (GSK) is a global healthcare company specialized in the research‚ development‚ manufacturing and marketing of pharmaceutical and consumer health-related products. The company has operations in 120 countries‚ with products being sold in over 150 countries. (Description) 2. As a dominant player in the pharmaceutical industry‚ GSK operates in an oligopolistic market. It is highly cash generative‚ with increased sales growth and shareholder
Premium Costs Economics Oligopoly
GlaxoSmithKline (GSK) is one of the largest and most profitable pharmaceutical companies in the world. This conglomerate is the product of multiple mergers of some of the leading companies in the industry. It was created in 2000 and at the time this case was written‚ had a market capitalization of $193.5 billion. The company’s most recent focus is on emerging markets‚ vaccines and consumer healthcare. When Sir Andrew Witty took over as CEO in 2008‚ he implemented a significant restructuring program
Premium Vaccine Pharmacology Pharmaceutical industry
GSK Marketing Planning | March 31 2013 | Calvin Cheung‚ Hussain Al Katib‚ Manpreet Budwal‚ Sandra Okechukwu | SOSTAC Review based on GlaxoSmithKline | Content Table of Contents 1.0 Introduction2 2.0 Situation Analysis3 2.1 PESTEL Analysis3 2.2 SWOT Analysis4 2.3 Boston Matrix5 2.4 Porter’s Five Forces Analysis6 3.0 Objectives8 4.0 Strategy9 4.1 Product9 4.2 Price9 4.3 Promotion9 4.4 Place10 4.5 Person10 4.6 Process10 4.7 Physical Evidence10 5.0 Tactics11 6.0 Action Plan12
Premium Marketing
b.pharma INTRODUCTION INTRODUCTION Drug Omeprazole Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia‚ peptic ulcer disease (PUD)‚ gastroesophageal reflux disease (GORD/GERD)‚ laryngopharyngeal reflux (LPR)‚ and Zollinger-Ellison syndrome. It was first marketed in the US in 1989 by AstraZeneca under the brand names Losec and Prilosec‚ and is now also available from generic manufacturers under various brand names. AstraZeneca
Premium Pharmaceutical industry Sales Generic drug
Term 2‚ 2010/11 MGMT003 Business‚ Government and Society (BGS) Instructor: Dr. Gilbert Tan An analysis of Case 29: Big Pharma’s Marketing Tactics Introduction The Big Pharma controversy is about the wide-scale marketing malpractices used by big pharmaceutical companies in America which resulted in a series of negative implications on consumers. It revolves around pharmaceutical companies‚ government regulators‚ health professionals (or “unprofessional”)‚ market consumers and the medical watchdogs
Premium Pharmaceutical industry Pharmacology Drug development
* SWOT Analysis of Manufacturing Industry * SWOT Analysis of the Power Industry * * * * Print this article 1. Strengths * The strengths of the pharmaceutical industry’s SWOT analysis document the internal industry components that are providing value‚ quality goods and services and overall excellence. The internal industry components can include physical resources‚ human capital or features the industry can control. For example‚ the pharmaceutical industry’s strengths
Premium Generic drug Management Porter five forces analysis
STRUCTURE – RATIO ANALYSIS | FINANCIAL MANAGEMENT | GROUP 10 | | MBA (BANKING AND FINANCE) | TERM II | SUBMITTED BY: | DEEPTI SHARMA | DEVANSHU JUNEJA | ROLL NO. : | 067 | 068 | MOBILE NO. : | 07737801787 | 09602869642 | INDIVIDUAL CONTRIBUTION | Undertook entire calculation and analysis for Anuh Pharmacy and Lincoln Pharmacy in addition to part analysis of Dishman Pharmacy and the industry ratios | Undertook entire calculation and analysis for Vivimed Laboratories
Premium Pharmaceutical industry Pharmacology Pharmacy
Beximco Pharma Submitted to: Husna Ara Lecturer‚ Department of Business Administration East West University Submitted by: Group: 3 Name | ID | Signature | Shajia Afrin | 2011-2-30-120 | | Shahena Akter | 2011-2-30-125 | | Sadia Akter Moury | 2011-2-30-119 | | Shoha Afrin | 2011-2-30-123 | | Lutfun Nahar Diba | 2011-2-40-176 | | Date of Submission: 12-07-2011 13 July‚ 2011 To‚ HUSNA ARA Lecturer‚ Department of Business Administration‚ East West University‚
Premium Balance sheet Pharmacology Pharmaceutical drug
INTRODUCTION 2. GROUP OF COMPANIES 3. FORMULATION OF MANUFACTURING 4. UNIQUE PROFILE OF SUN PHARMACEUTICAL 5. SWOT ANALYSIS 6. PESTLE ANALYSIS 7. PORTER’S FIVE FORCE ANALYSIS 8. FINDINGS & CONCLUSION 9. RECCOMMENDATIONS INTRODUCTION TO THE ORGANISATION Sun Pharmaceuticals was set up in 1983 and the company started off with only 5 products to cure psychiatric illness. Sun Pharma is best known worldwide as the manufacture of specialty Active Pharmaceuticals Ingredients and formulations.
Premium Pharmaceutical industry Pharmacology Generic drug
CASE STUDY Presentation Outline: Background Case Summary What is ‘crisis management’? Strategic Phase Reactive Phase Image Restoration Lessons Learnt Background: GlaxoSmithKline (GSK) is a British multinational pharmaceutical and consumer healthcare company that operates in over 100 countries. They have an extensive portfolio of products for major disease areas including asthma‚ cancer‚ infection‚ diabetes and digestive conditions Some products they produce that you might be familiar
Free Crisis management Management